Marshak Richard sold 544 shares of TriSalus Life Sciences, Inc. at $2.43 for −$1.32k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Commercial Officer
Chief Commercial Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,321.92Shares × reported price
Shares traded
544Common Stock
Price per share
$2.43Reported price. Read footnotes for ranges.
% of reported position traded
0.43%This security and ownership context
Holdings after
127,450Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 17, 2026, 4:02 PM ET1-day reporting delay
Accession
0001628280-26-074470Code S · Transaction 402934
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 127,994 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

TLSI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TLSI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +60%1w ago +56%1d ago +56%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person.